Article Versions Notes

Mangia A, Saponaro C, Vagheggini A, Opinto G, Centonze M, Vicenti C, Popescu O, Pastena M, Giotta F, Silvestris N. Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients? Cancers. 2019; 11(9):1393. https://doi.org/10.3390/cancers11091393

Mangia, Anita, Concetta Saponaro, Alessandro Vagheggini, Giuseppina Opinto, Matteo Centonze, Chiara Vicenti, Ondina Popescu, Maria Pastena, Francesco Giotta, and Nicola Silvestris. 2019. "Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?" Cancers 11, no. 9: 1393. https://doi.org/10.3390/cancers11091393

Mangia, A., Saponaro, C., Vagheggini, A., Opinto, G., Centonze, M., Vicenti, C., Popescu, O., Pastena, M., Giotta, F., & Silvestris, N. (2019). Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients? Cancers, 11(9), 1393. https://doi.org/10.3390/cancers11091393